Devices › Device types
FDA product code MAH · class 2 · Ear, Nose, Throat
Hearing aid, bone conduction, implanted: medical device reports filed with FDA
6,708 reports carry this product code, 1996–2026; 20 brands with a page.
- 6,708
- reports with this product code
- 0% of all MAUDE reports
- 489
- reports, 12 months to August 2026
- 603 in the 12 months before
- 0.5%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code MAH is FDA's classification for "Hearing aid, bone conduction, implanted" (ear, Nose, Throat panel), a class 2 device. 6,708 medical device reports carry this product code, 0% of the MAUDE database, from October 1996 to August 2026.
489 reports arrived in the 12 months to August 2026, down 19% from 603 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (96%), other (1.4%) and malfunction (0.5%). 20 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Asku | 947 | 210 | 1.1% | 47.1% |
| BIA400 Implant 4mm w Abutment 10mm | 815 | 68 | 0% | 0% |
| Ponto | 799 | 42 | 0% | 0% |
| BIA400 Implant 4mm w Abutment 12mm | 652 | 35 | 0% | 0.1% |
| BIA400 Implant 4mm w Abutment 8mm | 489 | 33 | 0% | 0% |
| BA400 Abutment 10mm | 412 | 18 | 0% | 0% |
| BA400 Abutment 12mm | 313 | 21 | 0% | 0% |
| Ba400 Abutment 8mm | 301 | 7 | 0% | 0.3% |
| BIA400 Implant 4mm w Abutment 14mm | 200 | 25 | 0% | 0.5% |
| Flange Fixture And Abutment | 97 | 0 | 0% | 0.3% |
| Vibrant Soundbridge | 33 | 82 | 0% | 38.7% |
| BIM400 Implant Magnet | 18 | 153 | 0% | 0.6% |
| Flange Fixture St 4mm W Baha Abutment | 15 | 9 | 0% | 0% |
| Bi300 Implant 3mm | 13 | 19 | 0% | 0% |
| BI300 Implant 4 mm | 12 | 28 | 0% | 0.6% |
| Bonebridge | 2 | 99 | 0% | 64.9% |
| Astral 100 - AMER | 1 | 92 | 1% | 98.2% |
| Nucleus Ci24re Ca Cochlear Implant With Contour Advance Electrode | 1 | 15 | 0% | 12.5% |
| Nucleus CI632 Profile Plus with Slim Modiolar Electrode | 1 | 461 | 0% | 3.5% |
| Nucleus Freedom Implant with Contour Advance Electrode | 1 | 189 | 0.2% | 11.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Cochlear Bone Anchored Solutions | 5,759 | 85.9% |
| Oticon Medical | 930 | 13.9% |
| Cochlear | 17 | 0.3% |
| Med-El Elektromedizinische Geraete | 2 | 0% |
| Resmed | 2 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Patient device interaction problem | 1,876 | 28% |
| Loss of osseointegration | 915 | 13.6% |
| Failure to osseointegrate | 559 | 8.3% |
| Insufficient device problem information | 132 | 2% |
| Loosening of implant not related to bone-ingrowth | 115 | 1.7% |
| Osseointegration problem | 54 | 0.8% |
| Detachment of device or device componentpart of the device came off | 33 | 0.5% |
| Inadequacy of device shape and/or size | 32 | 0.5% |
| Explanted | 22 | 0.3% |
| Therapeutic or diagnostic output failure | 20 | 0.3% |
| Extrusion | 19 | 0.3% |
| Patient-device incompatibilitythe device did not suit the patient | 12 | 0.2% |
| Biocompatibility | 8 | 0.1% |
| Unexpected therapeutic results | 8 | 0.1% |
| Device remains implanted | 7 | 0.1% |
| Device issuea problem with the device | 6 | 0.1% |
| Expulsion | 6 | 0.1% |
| Replace | 6 | 0.1% |
| Device appears to trigger rejection | 5 | 0.1% |
| Output problem | 5 | 0.1% |
Questions about hearing aid, bone conduction, implanted reports
What is product code MAH?
FDA's classification code for "Hearing aid, bone conduction, implanted", class 2, reviewed by the ear, Nose, Throat panel. Every device report carries the product code of the device involved.
How many reports carry this code?
6,708 reports through August 2026, 489 of them in the latest 12 months.
Which brands appear most often?
Asku (947), BIA400 Implant 4mm w Abutment 10mm (815), Ponto (799), BIA400 Implant 4mm w Abutment 12mm (652) and BIA400 Implant 4mm w Abutment 8mm (489). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.